Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maria Ines Bianconi"'
Autor:
Luz Angela Correa Ramirez, Kevin M. Elias, Izildinha Maestá, Sue Yazaki Sun, S. Otero, Antonio Braga, Maria Ines Bianconi, Ross S. Berkowitz, Jorge Rezende-Filho, Neil S. Horowitz, Marjory de Freitas Segalla Moreira, Gustavo Jankilevich
Publikováno v:
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Made available in DSpace on 2020-12-12T02:41:31Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-09-01 Background South America has a higher incidence of gestational trophoblastic disease than North America or Europe, but whether this impacts c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f44fc647eeaf42a6522c2e9813f4d9
Autor:
Mariángeles Díaz, Elida Alvarez, Gustavo Jankilevich, Silvia E. Hajos, Néstor Lago, Maria Ines Bianconi, Silvina Lompardía, S. Otero, Elsa Zotta, Matías Pibuel, Marilina Mascaró
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Hyaluronan (HA) is the major glycosaminoglycan present in the extracellular matrix. It is produced by some tumours and promotes proliferation, differentiation and migration among others cellular processes. Gestational trophoblastic disease (GTD) is c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9168a666a17f21cc7d4eec440de9dd78
https://link.springer.com/article/10.1007/s00418-017-1559-3
https://link.springer.com/article/10.1007/s00418-017-1559-3
Autor:
Luz Angela Correa Ramírez, Izildinha Maestá, María Inés Bianconi, Gustavo Jankilevich, Silvina Otero, Carlos Raúl Villegas Mejía, Rafael Cortés-Charry, Kevin M. Elias, Neil S. Horowitz, Michael Seckl, Ross S. Berkowitz
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia, Vol 44, Iss 8, Pp 746-754 (2022)
Abstract Objective There are few multinational studies on gestational trophoblastic neoplasia (GTN) treatment outcomes in South America. The purpose of this study was to assess the clinical presentation, treatment outcomes, and factors associated wit
Externí odkaz:
https://doaj.org/article/c7530bca781549b9b2a0ff3fda00e942
Publikováno v:
Gynecologic oncology. 106(1)
Background. Although most patients at high risk of Gestational Trophoblastic Neoplasia (GTN) respond to standard treatments, there is a group of patients that will die because of it. The use of new single or combination drugs in this population has b
Autor:
Gustavo Jankilevich, Maria Ines Bianconi, Marvin Albert Mizrahi, Mario Edmundo Barugel, Paula Micone, Claudio Storino
Publikováno v:
Journal of Clinical Oncology. 33:e12622-e12622
e12622 Introduction:Obesity has been highlighted as one of the main causes associated with cancer 1 2. The impact of BMI 3 to Overall Survival (OS) and disease-free survival (DFS) is controversial ...
Autor:
Aleydah Salazar, Joffre Amim-Junior, Sue Sun, Antonio Braga, Bruno Maurizio Grillo, José Mauro Madi, Sergio Lunardon Padilha, Maria Ines Bianconi, Maria do Carmo Fajardo, Gustavo Jankilevich, S. Otero, Izildinha Maestá, Juandyr Moreira de Andrade, Elza Maria Hartmann Uberti, Jorge Rezende-Filho, Lourdes Rodriguez, Eduardo Silveira, Maurício Viggiano, Rafael Cortés Charry
Publikováno v:
ResearcherID
e16508 Background: GTN is a curable disease. The quality of care following international guidelines and multidisciplinary dedicated teams are cornerstones to achieve successful results. Reports fro...
Autor:
Gabriela Lavelli, Maria Ines Bianconi, Carolina Sanchez, Gustavo Jankilevich, Maria Colica, Erika Stegmayer, Luciana Gennari, Karina O'Leary, Gabriela Marraco, S. Otero
Publikováno v:
Annals of Oncology. 24:iv63
Publikováno v:
Annals of Oncology. 23:ix330
Introduction Successful treatment of HRGTN patients is related to experienced teams, adequate scoring and standard treatments. Chemotherapy is the cornerstone of therapy and the dose and timing has paramount importance. Objectives To evaluate the pro
Publikováno v:
Journal of Clinical Oncology. 30:e15521-e15521
e15521 Background: Successful chemotherapy is the backbone of the treatment of patients with HR-GTN. However a percentage of this patients will recur to first treatment attempt. It is not defined how many lines of chemotherapy are required to achieve
Autor:
A. Zoricomba, D. Perez, Maria Ines Bianconi, Gustavo Jankilevich, S. Otero, M. Filomia, L. Koliren, C. Benavente, P. Micone, L. Rafailovici
Publikováno v:
Journal of Clinical Oncology. 23:875-875
875 Background: The age of breast cancer (BC) onset seems to have decreased during the last century in Buenos Aires.To validate this trend we tripled the number of patients(pts),including other Arg...